Repligen (RGEN) Equity Average (2011 - 2026)

Repligen (RGEN) has 16 years of Equity Average data on file, last reported at $2.1 billion in Q1 2026.

• Equity Average for Q1 2026 came in at $2.1 billion, up 6.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 6.4% YoY), and the FY2025 annual result was $2.0 billion, up 3.59% from the prior year.
• Equity Average improved to $2.1 billion in Q1 2026 per RGEN's latest filing, from $2.1 billion in the prior quarter.
• Over five years, Equity Average peaked at $2.1 billion in Q1 2026 and troughed at $1.8 billion in Q1 2022.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2025: Equity Average climbed 13.97% in 2022, then grew 0.71% in 2025.
• A 5-year view of Equity Average shows it stood at $1.9 billion in 2022, then gained by 5.15% to $2.0 billion in 2023, then increased by 1.29% to $2.0 billion in 2024, then increased by 5.01% to $2.1 billion in 2025, then climbed by 0.53% to $2.1 billion in 2026.
• Business Quant data shows RGEN's Equity Average at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.